Will Enovis stock go up?

According to Danelfin AI, Enovis has today an AI Score of 3/10 (Sell rating), because its probability of beating the market in 3 months (46.14%) is -4.67% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Enovis stock?

The Enovis target price is $37.35 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Enovis stock right now?

Enovis has today a Sell rating (AI Score 3/10), according to Danelfin AI. Its probability of beating the market in 3 months (46.14%) is -4.67% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Enovis stock is a good buy .

Is Enovis undervalued right now?

Based on analysts, the average price target upside for Enovis is +86.26% (1Y). According to Danelfin AI, Enovis has today an AI Score of 3/10 (Sell Rating).

What was the price range of Enovis stock over the past 12 months?

The Enovis stock price range over the past 12 months has been $20.05 - $35.94.

What is going on with Enovis stock in the last 3 months?

The Enovis stock performance in the last quarter has been -11.86%.

Does Enovis offer dividend payments?

No, Enovis does not currently pay dividends.

What is the current market capitalization of Enovis?

Enovis's market cap is $1.15B, as of 2026-07-02 08:00.

When is the next ENOV earnings report date?

ENOV will publish its next earnings report on 2026-05-07.

Enovis Corp (ENOV) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

ENOV AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Momentum+1.94%
Direction and strength of recent price movements

Sentiment-6.13%
How analysts and the market view the stock
Volatility-0.36%
How much the stock price tends to fluctuate
Valuation-0.12%
How the stock is priced relative to its fundamentals

ENOV probability advantage of beating the market (3M):

-4.67%

AI Score

Sell

Enovis (ENOV) has an AI Score of 3/10 (Sell) because, according to an overall analysis, it has a probability advantage of -4.67% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of ENOV (46.14%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
ENOV probability advantage of beating the market (3M)-4.67%
ENOV probability of beating the market (3M)46.14%

ENOV probability advantage of beating the market (3M): -4.67%

The AI-powered overall analysis of Enovis (ENOV) is based on the 26 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of ENOV:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Sentiment	Industry (GICS)	Health Care Equipment & Supplies	N/A	-4.24%
Technical	Chart Pattern (504d)	figure_62	N/A	+2.84%
Technical	Chart Pattern (180d)	figure_157	N/A	-1.83%
Technical	Technicals Impact (Long Tail)	-	N/A	+1.71%
Technical	Chart Pattern (252d)	figure_51	N/A	-1.69%
Technical	Performance (YTD)	-0.25%		+1.49%
Technical	Chart Pattern (60d)	figure_163	N/A	-1.46%
Technical	Distance from KAMA (20d)	-0.13%	N/A	+1.39%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-1.21%
Technical	Alpha Last Day	-0.03%		+1.17%
Technical	Upgrade to unlock			-1.14%
Fundamental	Upgrade to unlock			-0.98%
Sentiment	Upgrade to unlock			+0.83%
Sentiment	Upgrade to unlock			+0.83%
Fundamental	Upgrade to unlock			-0.81%

Rest of Alpha Signals: -0.61%

ENOV probability advantage of beating the market (3M)Total:-4.67%
ENOV AI Score

Significant changes Vs previous day

ENOV Short Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$20.05
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro)
Take Profit:$XXXXXPro (XXXXX
Pro
)

ENOV Proven Sell Signal & Price Forecast

This is the price chart for ENOV from January 1, 2026 until today. The chart indicates, in red, the 94 days when the stock received a Sell/Strong Sell rating (sell signals, AI Score 1 to 3).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Sell signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Sell signals

Forecast:

1 Month
3 Months
6 Months
1 Year

ENOV Average Past Performance & Loss Rate

Three months after its 1173 Sell signals since July 2026, ENOV had an average performance of xxxxxx and a xxxxxx Loss rate (negative performance).

1173 Past ENOV Sell Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				+1.17%
Average Alpha				-10.68%
Loss Rate (% Negative Perf.)				57.03%
% Negative Alpha				74.30%

ENOV Frequently Asked Questions

Will Enovis stock go up?
According to Danelfin AI, Enovis has today an AI Score of 3/10 (Sell rating), because its probability of beating the market in 3 months (46.14%) is -4.67% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Enovis stock?
Is it a good time to buy, sell, or hold Enovis stock right now?
Is Enovis undervalued right now?
What was the price range of Enovis stock over the past 12 months?
What is going on with Enovis stock in the last 3 months?
Does Enovis offer dividend payments?
What is the current market capitalization of Enovis?
When is the next ENOV earnings report date?

Enovis Corp Company Profile

Enovis Corporation functions as a global medical technology firm committed to creating distinct, clinically advanced solutions. In addition, the firm produces and markets medical apparatus utilized in procedures such as reconstructive surgery, physical therapy, rehabilitation, and pain management. The firm's operational sectors are split between Recovery & Prevention and Reconstructive divisions.

The Recovery & Prevention branch focuses on providing an array of orthopedic products and recovery sciences like solid and flexible orthopedic braces, thermal therapies, bone growth stimulators, vascular treatment systems and compressive garments. Alongside these offerings, they provide therapeutic footwear and inserts as well as electrical stimulator management tools. Enovis' physical therapy devices cater to an extensive demographic of healthcare professionals inclusive of orthopedic specialists, surgeons, general practitioners, pain management specialists physiotherapists podiatrists chiropractors athletic trainers among others.

Moving onto the Reconstructive segment of Enovis Corporation that operates an implant business offering a suite of joint reconstructive products that can be used from hip to finger including knee shoulder elbow foot and ankle reconstruction; moreover it also provides surgical productivity tools The company ensures a far-reaching distribution scheme for its products through independent distributors directly under the ESAB and DJO brands.

Enovis Corporation formerly operated under the moniker Colfax Corporation. It was founded in 1995 having its headquarters situated in Wilmington Delaware.

Sector:
Country:United States
Industry:
Address:2711 Centerville Road, Suite 400, Wilmington
Employees:7,802
Website:enovis.com

Pros

High switching costs for orthopedic implant systems

Demographic tailwinds from global aging population

Recurring revenue from consumable orthopedic products

Intellectual property protection for medical device designs

Operating leverage from established hospital sales channels

Cons

Extensive regulatory approval processes for new devices

Pricing pressure from healthcare payer reimbursement policies

Reliance on surgeon training and adoption for new products

Demand cyclicality for elective orthopedic procedures

Competition from diversified medical technology incumbents

Pros

Cons

Company

AI Score

Compare

NVSTEnvista Holdings Corp

FEEDENvue Medical, Inc

NVNOenVVeno Medical Corp

BVSBioventus Inc

OFIXOrthofix Medical Inc

Company

AI Score

Compare

ENOV Top 10 Industry Stocks

Health Care Equipment & Supplies

	Company	AI Score	Compare
1	PODDInsulet Corp
2	UTMDUtah Medical Products Inc
3	PHGKoninklijke Philips NV
4	ALCAlcon AG
5	TMDXTransmedics Group Inc
6	CVRXCVRx Inc
7	GUTSFractyl Health Inc
8	XTNTXtant Medical Holdings Inc
9	ESTAEstablishment Labs Holdings Inc
10	INMDInmode Ltd

	Company	AI Score	Compare

	Company	AI Score	Compare
1	COGTCogent Biosciences Inc

Company

AI Score

Compare

COGTCogent Biosciences Inc

Company

AI Score

Compare

ENOV Stock AI Analysis

Enovis Corp

ENOV Stock AI Analysis

Enovis Corp

ENOV AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

AI Score Explanation

Generating AI Score explanation

AI Score Alpha Factors

Alpha Signals: What Drives the AI Score

ENOV probability advantage of beating the market (3M): -4.67%

ENOV Short Trading Parameters

ENOV Proven Sell Signal & Price Forecast

ENOV Average Past Performance & Loss Rate

ENOV Frequently Asked Questions

Will Enovis stock go up?

What is the target price for Enovis stock?

Is it a good time to buy, sell, or hold Enovis stock right now?

Is Enovis undervalued right now?

What was the price range of Enovis stock over the past 12 months?

What is going on with Enovis stock in the last 3 months?

Does Enovis offer dividend payments?

What is the current market capitalization of Enovis?

When is the next ENOV earnings report date?

Enovis Corp Company Profile

Pros

Cons

Pros

Cons

ENOV Company Profile Summary

ENOV Related Investment Themes

ENOV Related Stocks

ENOV Top 10 Industry Stocks

Health Care Equipment & Supplies

ENOV Top 10 Sector Stocks

Health Care

ENOV Stock AI Analysis

Enovis Corp

NEW YORK STOCK EXCHANGE, INC.

Will Enovis stock go up?

What is the target price for Enovis stock?

Is it a good time to buy, sell, or hold Enovis stock right now?

Is Enovis undervalued right now?

What was the price range of Enovis stock over the past 12 months?

What is going on with Enovis stock in the last 3 months?

Does Enovis offer dividend payments?

What is the current market capitalization of Enovis?

When is the next ENOV earnings report date?

Pros

Cons

NEW YORK STOCK EXCHANGE, INC.

AI Score Explanation

Generating AI Score explanation

ENOV Proven Sell Signal & Price Forecast